home / stock / pacb / pacb news


PACB News and Press, Pacific Biosciences of California Inc. From 01/21/24

Stock Information

Company Name: Pacific Biosciences of California Inc.
Stock Symbol: PACB
Market: NASDAQ
Website: pacb.com

Menu

PACB PACB Quote PACB Short PACB News PACB Articles PACB Message Board
Get PACB Alerts

News, Short Squeeze, Breakout and More Instantly...

PACB - Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS

2024-01-21 16:50:33 ET More on Pacific Biosciences of California, AVITA Medical, etc. AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Pacific Biosciences' Revio And Onso Lead Looks Priced In For Now Reassessing Pacific Biosciences: Deep...

PACB - Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2023 Update

2024-01-18 21:08:20 ET Summary ARK Invest's 13F portfolio value increased by 29% this quarter, reaching approximately $16.89 billion. The top three holdings in the portfolio are Coinbase Global, UiPath, and Tesla. ARK Invest made new stakes in ProShares Bitcoin Strategy ETF an...

PACB - Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump

2024-01-17 21:22:40 ET Summary Shares of Oxford Nanopore declined by 33% after slower than expected growth in the second half of 2023. Positive outlook on the company, but profitability not expected until 2026. Challenging market with slow adoption of new technology, but new p...

PACB - PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions

PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions PR Newswire Existing HT CBB Kit Enables High-Throughput Extraction of HMW DNA Tailored for HiFi With an Updated Workflow for Animal Blood and Bacteria MENLO PARK, Calif. , ...

PACB - PacBio reports prelim Q4 revenue of $58.4M, shares fall

2024-01-08 10:59:39 ET More on Pacific Biosciences of California Pacific Biosciences' Revio And Onso Lead Looks Priced In For Now Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics Pacific Biosciences of California Q3 2023 Earni...

PACB - Pacific Biosciences of California, Regenxbio among healthcare movers

2024-01-08 10:00:05 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

PACB - PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively

PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively PR Newswire Ships a record number of PacBio sequencers in 2023, including 173 Revio™ systems, and announces record fourth quarter preliminary consumable revenue...

PACB - It's JPM time! Which medtechs are expected to issue updates this week?

2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...

PACB - PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference

PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire MENLO PARK, Calif. , Dec. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that managemen...

PACB - Learn to Evaluate (PACB) using the Charts

2023-12-21 14:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10